For instance, sphingomyelin phosphodiesterase 4 (SMPD4) was overexpressed in the late stage of clear cell renal cancer and acted as a biomarker for discriminating the early and late stages of ccRCC (22). This evidence concerns the gene SMPD4 and clear cell renal carcinoma.